- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05368532
Excitability Protocol: Voltage-gated Ion Channels
August 1, 2023 updated by: Jenny Tigerholm, Aalborg University
Novel Excitability Protocol to Identify Alteration of Voltage-gated Ion Channels
The purpose of subproject 1 is to evaluate the accuracy of a nerve excitability protocol in healthy subjects before testing the protocol in diabetic neuropathy patients.
The nerve excitability protocol has been derived by computational modeling to identify abnormalities of three subtypes of ion voltage-gated channels.
These three ion channels are all altered in animal models of diabetic neuropathy and, therefore, are likely candidates for generating the altered excitability in diabetic neuropathy patients.
The hypothesis for subproject 1 is that due to the unique dynamics of each subtype of voltage-gated ion channels, it is possible to identify abnormal voltage-gated ion channel alterations by altering the shape of the electrical stimulation.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jenny Tigerholm
- Phone Number: 99403451
- Email: jvt@hst.aau.dk
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Aalborg University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria: Healthy men and women in the age 18-80 years who speak and understand English.
Exclusion Criteria:
- Pregnancy or breast feeding
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Previous and present neurologic, musculoskeletal or mental illnesses (e.g., epilepsy, neuropathy, fibromyalgia and depression)
- Skin diseases
- Past history of conditions possibly leading to neuropathy
- Inability to cooperate
- Current use of medications that may affect the study, e.g., analgesics
- Previous traumatic experience of an electrical accident
- Consumption of alcohol or painkillers within the last 24 hours
- Participation in other pain studies throughout the study period
- Patients with cardiac diseases (e.g., pacemaker).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perception threshold for the excitability
Time Frame: Approximately 5 minutes to estimate.
|
The perception threshold will be estimated for a set of electrical stimuli.
The perception threshold is defined as the transcutaneous electrical current needed for the participant to perceive the stimulus.
The electrode will be placed on the arm.
The perception threshold will be estimated by the method of limits and the psi method.
|
Approximately 5 minutes to estimate.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensation
Time Frame: Approximately 5 minutes to estimate.
|
The investigator will ask the participant to rate the sensation of electrical stimulation by a questionnaire.
|
Approximately 5 minutes to estimate.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jenny Tigerholm, Aalborg University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 31, 2022
Primary Completion (Estimated)
December 1, 2023
Study Completion (Estimated)
March 1, 2024
Study Registration Dates
First Submitted
May 6, 2022
First Submitted That Met QC Criteria
May 6, 2022
First Posted (Actual)
May 10, 2022
Study Record Updates
Last Update Posted (Actual)
August 2, 2023
Last Update Submitted That Met QC Criteria
August 1, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- N-2020001-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
Clinical Trials on Temperature
-
Ege UniversityCompletedPrematurity | Feeding Disorder NeonatalTurkey
-
Karolinska InstitutetDanderyd Hospital; Stockholm South General HospitalWithdrawnSepsis | Critical Illness | Fluid Overload | Hemodynamic InstabilitySweden
-
University of BonnDLR German Aerospace CenterCompletedResting Energy ExpenditureGermany
-
Ajou University School of MedicineCompletedTrauma | Core TemperatureKorea, Republic of
-
Poitiers University HospitalCompletedContinuous Non Invasive Cutaneous Temperature | Zero Heat Flux Method | Esophageal Temperature | Arterial Temperature | Intracerebral TemperatureFrance
-
Ankara City Hospital BilkentCompletedHypothermia | Orthopedic Disorder | Hip ArthropathyTurkey
-
The University of Texas Health Science Center,...Zoll Medical Corporation; Vivian L. Smith Foundation for Neurologic ResearchTerminatedSubdural Hematoma, TraumaticUnited States, Japan
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Fudan UniversityNot yet recruitingCognitive Function | Cardiovascular System | Respiratory SystemChina
-
Fudan UniversityActive, not recruitingCognitive Function | Cardiovascular System | Respiratory SystemChina